Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of Zika Virus Maternal-Fetal Transmission
Effect of pregnancy and HIV on the development of tuberculosis
Insight and Optimization of Metalloprotein Inhibitors
Advancing the FDA Voluntary Retail Food Program Standards through Evaluation of Data/Informatics and targeted Oral Culture Training in Boulder County, CO
Northwestern Univ Program in Endo Diabetes & Hormone Act
Recently added grants:
Characterization of biased airway smooth muscle TAS2R agonists for treating asthma
Microglial remodeling of the extracellular matrix in memory circuits
BLRD Research Career Scientist Award Application
Elucidating hereditary transthyretin-mediated heart failure risk using machine learning, polygenic risk and recall by genotype approaches in African ancestry individuals
Structural Biology of Dopamine Signaling
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35000-8-0-1
Application #
7579487
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/ Mayo Clinic, Rochester
$2,258,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Limburg, Paul J. /
$2,257,713
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant